| Literature DB >> 34556816 |
Sarah Aherfi1,2,3, Djamal Brahim Belhaouari1,3, Lucile Pinault1,3, Jean-Pierre Baudoin1,3, Philippe Decloquement1,3, Jonatas Abrahao4, Philippe Colson1,2,3, Anthony Levasseur1,3, David C Lamb5, Eric Chabriere1,3, Didier Raoult1,2,3, Bernard La Scola6,7,8.
Abstract
The discovery of Acanthamoeba polyphaga Mimivirus, the first isolated giant virus of amoeba, challenged the historical hallmarks defining a virus. Giant virion sizes are known to reach up to 2.3 µm, making them visible by optical microscopy. Their large genome sizes of up to 2.5 Mb can encode proteins involved in the translation apparatus. We have investigated possible energy production in Pandoravirus massiliensis. Mitochondrial membrane markers allowed for the detection of a membrane potential in purified virions and this was enhanced by a regulator of the tricarboxylic acid cycle but abolished by the use of a depolarizing agent. Bioinformatics was employed to identify enzymes involved in virion proton gradient generation and this approach revealed that eight putative P. massiliensis proteins exhibited low sequence identities with known cellular enzymes involved in the universal tricarboxylic acid cycle. Further, all eight viral genes were transcribed during replication. The product of one of these genes, ORF132, was cloned and expressed in Escherichia coli, and shown to function as an isocitrate dehydrogenase, a key enzyme of the tricarboxylic acid cycle. Our findings show for the first time that a membrane potential can exist in Pandoraviruses, and this may be related to tricarboxylic acid cycle. The presence of a proton gradient in P. massiliensis makes this virus a form of life for which it is legitimate to ask the question "what is a virus?".Entities:
Mesh:
Substances:
Year: 2021 PMID: 34556816 PMCID: PMC8857278 DOI: 10.1038/s41396-021-01117-3
Source DB: PubMed Journal: ISME J ISSN: 1751-7362 Impact factor: 10.302
Fig. 1Confocal imaging of amoeba infected by P. massiliensis stained with MitoTracker Deep Red (in red) and with specific anti-P. massiliensis antibodies (in green).
A Co-localization of the MitoTracker signal (in red) with virus marked by specific antibodies (FITC) (arrows). B Merge of Bright-field, FTIC and MitoTracker fluorescence. The scales bar correspond to 2 µm.
Fig. 2Confocal imaging of TMRM staining of purified P. massiliensis virions.
A, B Viral mature particles stained with TMRM. C Bright-field channel. D Merge of Bright-field and TMRM showing the internalization of the TMRM signal in viral particles. The scales bar correspond to 5 µm.
Fig. 3Evaluation of the fluorescence intensity of TMRM after CCCP treatment.
A1–E1 Confocal imaging of TMRM staining following CCCP treatment of P. massiliensis particles. A1 Control experiment using untreated P. massiliensis particles. B1, E1: Confocal imaging of P. massiliensis virions treated with different concentrations of CCCP. A2–E2 Confocal imaging of TMRM staining after CCCP treatment of the positive control (S. aureus). A2 Control experiment showing untreated S. aureus. B2, E2 S. aureus treatment with a different concentration of CCCP. I Estimation of TMRM fluorescence intensity of P. massiliensis particles following CCCP treatment. II Estimation of TMRM fluorescence intensity of S. aureus following CCCP treatment. The scales bar correspond to 5 µm.
Fig. 4Recapitulative diagram of results obtained for each step of the TCA cycle.
Schematic representation of the TCA cycle showing the predicted ORFs of P. massiliensis with similarities to TCA cycle enzymes, and a summary of the results provided by qRT-PCR, RNA sequencing and proteomics.